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Abstract
Background: Major postoperative morbidity and mortality remain common despite efforts to improve patient
outcomes. Health information technologies have the potential to actualize advances in perioperative patient care,
but failure to evaluate the usability of these technologies may hinder their implementation and acceptance. This
protocol describes the usability testing of an innovative telemedicine-based intra-operative clinical support system,
the Anesthesiology Control Tower, in which a team led by an attending anesthesiologist will use a combination of
established and novel information technologies to provide evidence-based support to their colleagues in the
operating room.
Methods: Two phases of mixed-methods usability testing will be conducted in an iterative manner and will evaluate
both the individual components of the Anesthesiology Control Tower and their integration as a whole. Phase I testing
will employ two separate “think-aloud” protocol analyses with the two groups of end users. Segments will be coded
and analyzed for usability issues. Phase II will involve a qualitative and quantitative in situ usability and feasibility
analysis. Results from each phase will inform the revision and improvement of the Control Tower prototype
throughout our testing and analysis process. The final prototype will be evaluated in the form of a pragmatic
randomized controlled clinical trial.
Discussion: The Anesthesiology Control Tower has the potential to revolutionize the standard of care for
perioperative medicine. Through the thorough and iterative usability testing process described in this protocol,
we will maximize the usefulness of this novel technology for our clinicians, thus improving our ability to implement
this innovation into the model of care for perioperative medicine.
Trial registration: The study that this protocol describes has been registered in clinicaltrials.gov as NCT02830126.
Keywords: Usability, Feasibility, Telemedicine, Clinician decision support, Health information technology,
Human-computer interaction
Background
Despite major advancements in the safety of anesthetic
techniques and therapeutics, the risk of patient morbidity
and mortality related to surgery persists. Some of this risk
is unavoidable and either is inherent to the nature of the
surgical procedure itself or is attributable to a characteris-
tic of the patient that is not in an immediate way modifi-
able [1–3]. There are, however, factors that do fall under
the control of the anesthetic team that have been shown
to affect the patient’s immediate and long-term health
[4–7]. Information technology-driven decision support
has been shown to optimize management of these
factors, leading to improvement in physiological mea-
sures, such as blood pressure stability [8] and glucose
control [9, 10]. This decision support can aid members of
the anesthesia care team, who often experience informa-
tion overload in the operating room that can limit their
implementation of evidence-based practice. Health IT
tools that work to advance and implement decision
support systems are being championed in the demand for
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enhanced quality in health care [11, 12]. A critical compo-
nent of the implementation process is the inclusion of
usability analysis of the health IT throughout its lifecycle,
beginning in the development phase and continuing into
the post-implementation period [13]. Usability is an essen-
tial feature of the successful implementation of novel
information technologies [14–16] and has significant
impact on productivity and performance [13] in addition
to the acceptance and safety of health IT systems [13].
At our institution, we are developing a novel
telemedicine-based intervention for the operating room,
the Anesthesiology Control Tower (ACT), which is simi-
lar in concept to an air traffic control tower for a busy
airport. The clinicians in the Anesthesiology Control
Tower (ACTors) will monitor active operating rooms
(ORs) in real time by using several electronic health re-
cords at our institution. Just as an air traffic control
tower monitors each aircraft and delivers additional
information and alerts to the pilot and co-pilot, the
ACT will engage with teams of anesthesia clinicians in a
similar fashion to assist them in providing safe, effective,
and efficient care for their patients. The ACT interven-
tion will be evaluated in the form of a pragmatic,
comparative effectiveness randomized controlled trial
(NCT02830126). However, prior to the implementation
of the ACT, it will be crucial to ensure that it is a useful
and usable resource for the clinicians for whom it is
developed, as usability is a critical feature of the success-
ful implementation of novel information technologies
[14–16], with a significant impact on productivity and
performance [13] in addition to the acceptance and
safety of health IT systems [13]. The primary objective
of the protocol described in this paper is to evaluate the
usability of the ACT by gathering perceptions of key
stakeholders and end users of the ACT and secondarily
to assess the feasibility of its implementation in routine
care, prior to conducting a pragmatic trial evaluating the
ACT. Usability testing will be performed in an iterative
manner throughout the design and implementation
stages and will focus on outcomes related to effectiveness,
efficiency, and acceptability. This protocol describes two
phases of mixed-methods (qualitative and quantitative)
usability and feasibility testing [15, 17–20] of the
ACT structure, including the software platforms that
it employs.
Methods
The full description of ACT is available in Appendix 1.
This includes a description of one of the software pro-
grams used in the ACT, called AlertWatch® (Ann Arbor,
MI), which is a clinical monitoring and alerting system
(Appendix 1, Figs. 1, 2 and 3). The specific and unique
platform described in this protocol, AlertWatch (AW)
Tower Mode, will be customized and refined through
this research. While the developers of AlertWatch will
be involved in refinements of the ACT based on the
findings of our study, they will have no input on the de-
sign of the study nor how it is carried out and no in-
volvement in the data collection and analysis process.
The initial design of the AW Tower Mode is based on
input from experts in clinical anesthesiology and medical
informatics. We anticipate that prototype revision and
improvement will occur throughout the usability testing
and analysis process.
Two phases of usability testing will be conducted in
series, as described fully below. A mixed-methods
approach of qualitative and quantitative analysis will be
employed. The first phase of testing will be an exploratory
analysis that employs a “think-aloud” approach, which is
well suited for identifying key usability issues and barriers
to adoption of new technologies [21]. It will include paral-
lel testing with two groups of end users (Table 1). The
second phase of testing will involve in situ use of the ACT
by end users and will further focus on the outcomes of
efficiency, efficacy, and learnability of and satisfaction with
the ACT [22, 23].
Participants in this study will be recruited from the de-
partment of anesthesiology through approved use of the
departmental distribution list, which is the most common
method of communication within the department. An ini-
tial recruitment email will be sent to all the members of
each relevant participant group (Table 1). Additional study
information will be provided to any interested parties, and
those who express interest in joining the study will be
formally consented for participation.
During the study, access to data files will be strictly lim-
ited to members of the research team. All computer files
will be stored on an encrypted server, with additional
password protection for any file that contains identifying
information. Physical copies of surveys etc. will be stored
in a locked location to which only the research team has
access. All physical data files and all recordings will be
destroyed at a pre-specified time after collection.
Phase I: usability analysis with a “think-aloud” protocol
Phase Ia
Participants will be recruited via email from the groups
of clinicians who would potentially staff the ACT
(ACTors), namely, attending anesthesiologists and senior
anesthesiology residents. All attending and senior
resident anesthesiologists in the department will be
eligible to participate. Eight to ten participants are an
appropriate number to identify the majority of surface-
level usability problems [24], and three to five partici-
pants per testing round are cost-efficient, maximizing
identification of issues while reducing redundancy [25].
A total of 12–15 participants will participate.
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Phase Ib
Participants will be recruited via email from the groups
of clinicians who are potential recipients of the ACT
support (clinicians in the OR—or CORs), namely,
attending anesthesiologists, anesthesiology residents, and
certified registered nurse anesthetists (CRNAs). A total
of 10–15 participants will be included. There will be no
overlap with participants in phase Ia, but there are no
other exclusion criteria.
Procedure
Phase Ia: “think-aloud” with ACTors Participants will
receive an orientation to the ACT and a description of
the tasks that they are to accomplish. Sessions will be
conducted by the authors in the room that houses the
ACT (TM, FW, MB); one or two authors will be present
per session without additional observers. These authors
are members of the department of anesthesiology who
do not have any supervisory roles in relation to partici-
pants in the study (resident physician, medical student,
and research staff member, respectively). These authors
will receive training on the administration of usability
testing scenarios. During the sessions, participants will
use available clinical applications to monitor active
operating rooms and address alerts generated by the
AW Tower Mode platform. Alerts are addressed by
documenting an assessment and recommended action
for each alert. Users will verbalize all thoughts, feelings,
and questions as they navigate through specific aspects
of the software programs and the ACT layout and design
to complete their tasks. The research team members will
prompt participants only if 20 s [21] or more elapses
without verbalization from the participant. Sessions will
be audio recorded. Observations and field notes from
the research team will be included to provide additional
insight. Participants will complete 20 min of testing.
This will be followed by a debriefing session that will
employ open-ended questions to obtain feedback on
specific issues (Appendix 2). The total length of sessions
will be approximately 50–60 min.
At the end of each session, participants will complete
the NASA Task Loading Index (NASA-TLX [26–28]),
the 10-item System Usability Scale (SUS [29]), and the
19-item Computer System Usability Questionnaire
(CSUQ [30]). The SUS and the CSUQ are appropriate
for subjective ratings of usability. The SUS offers a final
score that ranges from 0 to 100, with a “passable” score
above 70 [31]. The CSUQ offers a total score ranging
from 0 to 7, in addition to three subscale scores (system
usefulness, information quality, and interface quality).
Phase Ib: “think-aloud” with CORs Sessions will take
place in a conference room on the medical campus of
the hospital complex and will be administered by one
author (TM) with a second author as an observer (FW).
Participants will be informed of the purpose and format
of the procedure and will receive an orientation to how
the ACT will function. After this, open-ended questions
will be used to prompt participants to provide their ini-
tial reactions to the ACT intervention. Subsequently, the
research team member will present clinical scenarios
that invite the participant to think about interacting with
the ACT as a recipient of the ACT support. Participants
will be instructed to imagine themselves in each scenario
and to voice all thoughts that arise as they do so. After
participants have had the opportunity to share their
thoughts freely for each scenario, a short series of open-
ended questions (Appendix 2) will be used to obtain
COR feedback with regard to specific features of the
ACT, such as the usefulness of particular alerts and of
different methods of communication with the ACT.
Sessions will be audio recorded. Field notes and observa-
tions from the research team member will again be
included to provide additional insight. Sessions are
expected to last approximately 30 min.
Data analysis
Given that the “think-aloud” and similar methods often
slow task completion and thought processes [21], the
focus of analysis will be on qualitative usability data via
content analysis, although a few relevant quantitative
measures will be included. Participant demographics will
be reported with descriptive statistics. Mean scores from
the SUS, the NASA-TXL, and the overall CSUQ score
and subscale scores will be calculated and reported in
addition to 95% confidence intervals. Quantitative data
from phase Ia will include time to task completion and
rate of task completion.
Audio recordings from each participant in both phase
Ia and phase Ib will be professionally transcribed. The
investigators will review the transcripts to identify
Table 1 Participant groups at each stage of testing
Stage of
testing
Description Potential Participant
Groups
Phase Ia “Think-aloud” analysis for
physicians
staffing ACT
Attending
anesthesiologists
Anesthesiology
residents
Phase
Ib
“Think-aloud” analysis for
clinicians receiving
ACT support
Attending
anesthesiologists
Anesthesiology
residents
Certified registered
nurse anesthetists
Phase II Mixed in situ usability and
feasibility analysis
Attending
anesthesiologists
Anesthesiology residents
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themes and create a codebook with themes and
subthemes surrounding the usability of the ACT [32].
We will use a qualitative data analysis software program
(NVivo®) to organize and code the transcripts. We will
perform a content analysis of key themes based on the
frequency and level of emotive force expressed by partic-
ipants. Themes will be examined within and across user
groups (physician anesthesiologists, CRNAs). Research
team members trained in qualitative methods will
perform the coding independently until inter-rater reli-
ability is reached. Minor discrepancies will be resolved
through discussion and consensus. If there are major
discrepancies, we will refine the codebook and recode.
Decisions to modify components of the pilot ACT
during the usability testing will be determined by the in-
vestigative team, based on participant feedback, and will
occur in an iterative fashion.
Phase II: in situ usability and feasibility testing
Participants
Participants will include groups of clinicians who would
be eligible to staff the ACT (ACTors), namely attending
anesthesiologists and anesthesiology residents, who will
be recruited via email. Over the course of this phase, we
expect to include 10 subjects [24, 25]. Subjects who
complete phase Ia or phase Ib will be eligible to partici-
pate in phase II. Resident physicians will participate for
ten consecutive business days, due to scheduling con-
straints at our institution. Attending anesthesiologists
will participate one business day at a time and may
participate more than once.
Procedure
During the sessions, ACTors will use several different soft-
ware programs to remotely monitor active operating room
locations in real time. No research staff will be present.
Orientation videos and documents will be provided to par-
ticipants. They will address alerts that are created within
AW Tower Mode (see Appendix 1), but they will not
interact with CORs. Other than the lack of interaction be-
tween ACTors and CORs, this testing involves a functional
prototype of AW Tower Mode and live software programs.
A log of all alerts and ACTor responses, including ACTor
comments on individual alerts and the documented level
of significance for each alert, will be automatically gener-
ated and stored on a secure server.
All participants will complete the aforementioned 10-
item System Usability Scale (SUS [29]), the 19-item
Computer System Usability Questionnaire (CSUQ [30]),
and the NASA Task Load Index (NASA-TLX [26]). Resi-
dent physicians will complete these scales on days 1, 5,
and 10. Attending physicians will complete these scales
each day that they are in the ACT. In addition, ACTors
will have the opportunity to provide written feedback on
a daily basis.
Data analysis
This phase of in situ testing will allow us to further
evaluate the usability of the ACT and the feasibility of
implementation. Demographics will be included with
descriptive statistics. Mean scores and 95% confidence
intervals for the SUS, the NASA-TXL, and the CSUQ
scale and subscale will be calculated and reported for
assessment of subjective satisfaction and usability. Any
written feedback from participants will be coded using
standard techniques for analyzing qualitative data [33].
The feasibility of implementing the ACT will also be ex-
amined through analysis of AW data logs for measures
of effectiveness and efficiency in this near real-world
setting [15, 17, 19, 34–36]. Effectiveness, or the degree
to which users are able to succeed in achieving their
goals [20], can be described as the “accuracy and com-
pleteness” with which tasks are accomplished [34].
Methods of assessing effectiveness include evaluating the
quantity and quality of task completion [17, 34]. In this
phase of in situ testing, we will assess effectiveness by
examining data such as the number of alerts that are
successfully addressed and the number of patients that
are evaluated. We will also evaluate some measures of
efficiency such as the rate at which alerts are addressed,
rate of missed alerts, and number of errors.
Patterns in alert responses will also be analyzed.
Learnability as part of a feasibility assessment will be
determined by evaluating changes in performance of
ACTors across levels of experience. The usefulness of
individual alerts will be determined by the frequency
with which they are rated as significant or insignificant.
Changes to the ACT based on information obtained
throughout this phase, including the revision of AW
alerts, will be made based on the judgment of the inves-
tigative team.
Discussion
Many barriers exist to the implementation of novel
health information technologies. Thorough and contin-
ual evaluation of the usability of such technologies is
critical. A variety of approaches to usability assessment
have been employed. These include cognitive walk-
through methods [37], focus groups [16], surveys [38],
and “think-aloud” protocol analysis [37, 39–42]. A com-
bination of methods is often more powerful than single
methods in isolation [43]. Furthermore, “near-live” test-
ing often discover concerns that would have otherwise
been missed and is important in the evaluation of the
feasibility of implementing a new technology [39, 44].
Therefore, in this protocol, we employ a combination of
formal and real-world mixed-methods usability testing.
Murray-Torres et al. Pilot and Feasibility Studies  (2018) 4:38 Page 4 of 9
The formal think-aloud usability sessions with two
groups of end users in phase I will provide rich informa-
tion on surface-level usability problems actually encoun-
tered by these users [37]. This data will inform the
development and refinement of the ACT intervention,
particularly in the early phases of design and implemen-
tation. “Think-aloud” testing is well suited to identify
barriers to adoption for new technologies [12], although
limitations of this method include the potential for
hindering cognitive processes, particularly for tasks that
involve a high cognitive load [45]. We anticipate that the
phase II in situ qualitative and quantitative usability test-
ing, with its heightened fidelity, will provide additional
and complementary insight into usability and workflow
concerns in a more realistic setting. Real-world testing
such as this often discovers concerns that would have
otherwise been missed in exploratory or formal usability
testing [39, 44]. By analyzing a combination of data logs
and user questionnaires, we will obtain results pertaining
to major usability elements, namely, efficacy, efficiency,
learnability, and satisfaction [20, 22, 35, 43, 46], that will
allow us to ensure a useful and usable resource for our
clinicians.
Usability testing throughout the lifecycle of a given
technology is a crucial component of the successful
implementation of such technologies [36, 43], and the
results of our iterative analyses will inform and refine
the development of our intervention, particularly the
AW Tower Mode platform. This Tower Mode platform
is a customized product being specifically created and
designed for the purpose of instituting the ACT and for
our future randomized controlled trial. Although we are
testing with a limited sample size, we anticipate that the
results of the usability analysis described in this paper
will provide a sufficient breadth and depth of informa-
tion to allow us to ensure that the platform, which plays
an integral role in the ACT, incorporates the actual
needs of our users [24].
The planned pragmatic RCT will continue to evaluate
user experience in real-world implementation settings to
capture additional information about usability. For
example, the current study is designed to evaluate the
usability of the ACT and its software programs, prior to
the initiation of the randomized controlled trial in which
ACTors will be providing support to anesthesia clini-
cians in the OR. The usability of the modes of inter-
action between ACTors and CORs will not assessed
with the present methods, and we do expect this to have
an impact on the fully functional ACT. Therefore, in our
future randomized controlled trial involving the ACT
intervention, we plan to implement post-implementation
analyses [13] that evaluate and refine the ACT to ensure
that it is a useful and usable resource for our clinicians
in an actual real-world setting. We anticipate that some
of these analyses will be in the form of surveys with both
closed and open-ended responses that are administered
to the members of the anesthesia department.
The ACTors in our study will be monitoring up to 50
patients at a time, a novel model for anesthesia care that
deviates significantly from the traditional model in
which one anesthesiologist is responsible for no more
than four rooms. The ACT will demand a high level of
cognitive functioning. This level of cognitive functioning
necessitates resources that have been thoroughly exam-
ined for design and usability flaws. Thus, this series of
iterative usability testing and improvement is vital to the
development and implementation of our innovative
intervention.
Appendix 1
ACT description
ACTFAST context
The current study describes one part of our larger effort
to implement the Anesthesiology Control Tower (ACT), a
novel, telemedicine-based intervention for the operating
suite. The purpose of the research described in the current
protocol is to use iterative usability testing over the course
of approximately 6 months, in order to create a maximally
useful and usable resource for our clinicians. A second,
concurrent study by our group (Anesthesiology Control
Tower: Forecasting Algorithms to Support Treatments, or
ACTFAST2) is working to develop, refine, and validate
forecasting algorithms to predict negative patient trajec-
tories; such algorithms will serve to help inform ACT
interventions. Our final phase of investigation will be a
yearlong comparative effectiveness randomized controlled
trial (Anesthesiology Control Tower: Feedback Alerts to
Supplement Treatments, or ACTFAST3; NCT02830126)
to demonstrate the utility of the ACT in improving adher-
ence to clinically relevant practice guidelines and to evalu-
ate the effect of the ACT on surrogate measures of patient
outcome. In this trial, each of our institution’s adult ORs
will be randomized on a daily basis either to a control
group or to an experimental group in which anesthesia
providers in those ORs will receive the support of the
ACT. This support will be communicated in the form of
additional alerts sent by the physicians in the ACT, whose
responsibility is to filter and prioritize information, thus
maximizing alert quality and minimizing false alarms.
ACT technology
One of the key components of the ACT technological in-
frastructure is an advanced clinical monitoring and display
system called AlertWatch ® (Ann Arbor, MI). AlertWatch
(AW) uses a multi-threaded Java-based server to collect
and integrate clinical information from multiple distinct
data sources for presentation in a simplified and intuitive
manner (see Figs. 1, 2 and 3). AW provides alerts based
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on its continual analysis of the current patient state; when
patient parameters fall outside of predetermined set
points, AW triggers written and auditory alarms within
the patient display and on the census view. The AW
Tower Mode platform used in this study is distinct from
the commercially available product in many ways and will
be refined based on the results of the present study.
AlertWatch and all additional electronic records used
by our hospital are available via secure Internet connec-
tion to clinicians at any physical location in the world,
allowing for the creation of our remote ACT. This in-
cludes our anesthesia information management system,
MetaVision (iMDsoft®, Needham, MA; Centricity, Gen-
eral Electric Healthcare), which contains both manually
entered data and automatically recorded physiologic data
for the perioperative period.
ACT structure
The ACT is physically housed within the hospital complex
and is remoted from the physical operating rooms. This
Fig. 1 AlertWatch Tower Mode census view. From this view, clinicians in the ACT can obtain a brief overview of all the patients in the ORs. Alerts
and abnormal physiologic and laboratory parameters are represented by squares and triangles, respectively; checkmarks indicate alerts that must
be addressed by the ACT. These groups of alerts are unique to the AW Tower Mode and will be refined based on the results of the present study.
Clicking on an OR accesses the detailed information for that OR
Fig. 2 AlertWatch Tower Mode patient display. Organ systems are depicted and labeled with relevant physiologic variables and values. Colors
outlining organs indicate normal (green), marginal (yellow), or abnormal function (red). The left side of the display shows patient characteristics
and case information. Information regarding the actual patient’s comorbidities can be accessed by selecting the organ system or laboratory study
of interest. Text alerts are present on the right-hand side of the screen. The black checkmark at the bottom of the left panel indicates that there
is an active alert for the ACT clinicians to address; clicking on the checkmark opens the case review dialogue (Figure 3)
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room includes three computers: two with two monitors
and one with three monitors (one being a flat panel TV
screen). An additional flat panel TV screen is powered by
the third computer. The presence of additional monitors
allows multiple AW windows to be visible, in addition to
providing space for the separate, necessary software pro-
grams that will be needed. All software (i.e., our electronic
medical record, our anesthesia information management
system, and AW) either is accessible on these computers
through desktop icons or links through our department’s
webpage. A guide to the ACT and an AW help guide are
provided in a physical format in addition to electronic
copies. Two landline telephones and one iPhone will be
available in the randomized control trial.
The ACT will be staffed by attending anesthesiologists
and anesthesiology residents who are in their final year
of training. The main role of these trained clinicians
(referred to as “ACTors”) is to monitor all active ORs by
making use of AlertWatch, the hospital’s EMR, and
the anesthesiology information management system.
ACTors will assess and address alerts within the AW
Tower Mode platform (Figure 3) and will use their
clinical judgment to determine whether a particular
alert warrants contact with the clinicians in the OR
(CORs) to provide additional support.
Appendix 2
Debriefing scripts
Debriefing script for phase Ia (ACTor sessions)
Thank you for filling out the questionnaires. Before you
leave, I would love to talk briefly about your overall
impression of the ACT.
Right now how do you feel about the ACT after the
session today?
Were there problems that you encountered with any of
the software?
Were there problems that you encountered with the
physical set up?
Was there anything in the AlertWatch program or the
other software that you think worked well?
Was there anything in the physical set up of the ACT
that you think worked well?
Debriefing script for phase Ib (COR sessions)
For each case scenario:
What thoughts come to your mind as you imagine this
[scenario]?
Would you want to communicate with the ACT? If so,
what would you communicate?
Do you think the ACT would be helpful in this
situation?
If yes, what makes it helpful?
If not, what keeps it from being helpful?
Could it ever be helpful?
For the final debriefing:
Now that we are finished with that part [of the
session], do you have additional general thoughts about
the ACT?
What are instances in which you think it would be
beneficial to receive an alert or assistance from the
ACT?
If participant cannot think of instances, prompt
further: is there any clinical situation that you can think
of in which it would be helpful to receive alerts from the
ACT?
What are instances in which it would be not be
beneficial or helpful to receive an alert?
What form of alert, phone call, text, or page, would be
most helpful? Would that ever change?
Do you have any other feedback, concerns, or questions
before we end?
Fig. 3 Case review. This popup window allows physicians in the ACT (ACTors) to document their assessment of alerts and what actions they
would recommend. This is a feature of AlertWatch that is unique to the ACT Tower Mode platform. ACTors successfully assess and address an
alert by documenting their assessment of the significance of the alert and by documenting what action they would recommend taking, if any
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